Protalix BioTherapeutics (PLX) Net Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 9,006.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,006.00 |
| Dec 31, 2025 | -10,659.00 |
| Sep 30, 2025 | -450.00 |
| Jun 30, 2025 | 1,887.00 |
| Mar 31, 2025 | 8,681.00 |
| Dec 31, 2024 | 29,547.00 |
| Sep 30, 2024 | 3,592.00 |
| Jun 30, 2024 | -6,256.00 |
| Mar 31, 2024 | -8,994.00 |
| Dec 31, 2023 | -19,890.00 |
| Sep 30, 2023 | 725.00 |
| Jun 30, 2023 | 10,715.00 |
| Mar 31, 2023 | -1,844.00 |
| Dec 31, 2022 | 4,011.00 |
| Sep 30, 2022 | 1,048.00 |
| Jun 30, 2022 | 11,596.00 |
| Mar 31, 2022 | 3,756.00 |
| Dec 31, 2021 | -7,900.00 |
| Sep 30, 2021 | 658.00 |
| Jun 30, 2021 | -13,871.00 |
| Mar 31, 2021 | -5,854.00 |
| Dec 31, 2020 | 84.00 |
| Sep 30, 2020 | -1,699.00 |
| Jun 30, 2020 | 2,506.00 |
| Mar 31, 2020 | 7,817.00 |
| Dec 31, 2019 | 31,589.00 |
| Sep 30, 2019 | 81,218.00 |
| Jun 30, 2019 | 36,233.00 |
| Mar 31, 2019 | 9,049.00 |
| Dec 31, 2018 | 26,813.00 |
| Jun 30, 2016 | -8,985.00 |
| Mar 31, 2016 | -4,258.00 |
| Mar 31, 2015 | 14,223.00 |
| Mar 31, 2014 | 1,426.00 |
| Dec 31, 2013 | 107,812.00 |
| Sep 30, 2013 | -9,785.00 |
| Jun 30, 2013 | -34,135.00 |
| Mar 31, 2013 | 3,256.00 |
| Dec 31, 2012 | -49,247.00 |
| Sep 30, 2012 | 62,517.00 |
| Jun 30, 2012 | 185,202.00 |
| Mar 31, 2012 | -3,504.00 |
| Dec 31, 2011 | 37,736.00 |
| Sep 30, 2011 | -68,502.00 |
| Jun 30, 2011 | -92,561.00 |